November 27, 2024

Artica Therapeutics announces establishment of scientific advisory board

March 21, 2024

Artica Therapeutics appoints Piet Wigerinck to its Board of Directors

November 2, 2023

Artica Therapeutics closes €12M seed investment to develop covalent therapeutics for autoimmune and inflammatory disorders

April 18, 2023

Artica Therapeutics successfully secures Mibiton financial lease funding